Retrieve all available abstracts of the following 351 articles: HTML format
Single Articles
GARDNER JE, Jung K, Pluot M, Sherertz T, et al Human papillomavirus infection among patients with cervical cancer in Cambodia.
BMC Womens Health. 2025;25:413. PubMed Abstract available
CHEN Y, Xie J, Xie B, Zhong H, et al Integrated proteomic and lipidomic analysis revealed potential plasma biomarkers
for cervical cancer.
J Pharm Biomed Anal. 2025;267:117131. PubMed Abstract available
GAO F, Shi H, Wang H, Wang J, et al Extracellular matrix-related genes-based prognostic signature for cervical
cancer: association of LAMA4 expression with prognosis and response to
immunotherapy.
Front Oncol. 2025;15:1562115. PubMed Abstract available
HIGASHI RT, Quirk L, Kruse G, Chen PM, et al Process mapping to compare and improve management of abnormal cervical cancer
screening results in two U.S. healthcare systems within the PROSPR Consortium.
Cancer Epidemiol Biomarkers Prev. 2025. PubMed Abstract available
LIU H, Yu L, Majerciak V, Meyer TJ, et al The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human
papillomavirus type 16-infected cervical cancer cells.
Elife. 2025;13:RP102681. PubMed Abstract available
MOHAMMED E, Taye G, Assefa M, Addissie A, et al Effect of health education on cervical cancer screening uptake and knowledge
among target women in Addis Ababa: A randomized controlled trial.
Cancer Prev Res (Phila). 2025 Aug 29. doi: 10.1158/1940-6207.CAPR-25-0188. PubMed Abstract available
BOOTH K, Bryant J, Chandra S, Davies C, et al Advancing equity: the urgent need to include trans and gender diverse people in
cervical cancer prevention in Australia.
Med J Aust. 2025 Aug 29. doi: 10.5694/mja2.70041. PubMed
ELI AV, Kasten BB, Mayer CM, Samant R, et al Contemporary Status and Frontiers of Cervical Cancer Screening in the United
States.
Cancer Prev Res (Phila). 2025 Aug 29. doi: 10.1158/1940-6207.CAPR-25-0118. PubMed Abstract available
ASAI-SATO M, Sakaguchi M, Kanemura S, Morishima T, et al Subsequent primary cancer incidence in cervical cancer survivors: insights from a
comprehensive cohort study utilizing combined Japanese population-based cancer
registries.
J Gynecol Oncol. 2025 Aug 25. doi: 10.3802/jgo.2026. PubMed Abstract available
MEKURIA S, Assiged N, Biazin H, Borgfeldt C, et al Assessing the feasibility of HPV screening for cervical cancer in pregnant women
in Ethiopia.
Sci Rep. 2025;15:31771. PubMed Abstract available
EFFAH K, Tekpor E, Ohene-Bredu Y, Ibrahim S, et al Assessing high-risk human papillomavirus-based cervical precancer screening
recommendations and implications among women aged 60/65 years and older in Ghana.
Sci Rep. 2025;15:31723. PubMed Abstract available
LI L, Wu H, Chen Y, Shen Z, et al Influence of Pre-Vaccination HPV Status on Vaccine Effectiveness Among Chinese
Women: A Multicenter Cross-Sectional Study.
Cancer Rep (Hoboken). 2025;8:e70294. PubMed Abstract available
LEHTINEN T, Zhang L, Sundquist K, Sundquist J, et al Elevated Risk of HPV-Associated Oropharyngeal Cancers in Husbands of Women With
Anogenital Cancer.
Cancer Rep (Hoboken). 2025;8:e70333. PubMed Abstract available
PARK SJ, Koh JW, Lee TB, Han SI, et al Biological Role of Replication Factor C Subunit 4 in Cervical Cancer Cell
Progression.
Anticancer Res. 2025;45:3701-3710. PubMed Abstract available
DU T, Li C, Grzegozek M, Huang X, et al PET/CT radiomics for non-invasive prediction of immunotherapy efficacy in
cervical cancer.
J Xray Sci Technol. 2025 Aug 28:8953996251367203. doi: 10.1177/08953996251367203 PubMed Abstract available
SOHAIL SK Pregnancy health literacy and willingness for HPV Testing among pregnant women in
Lahore, Pakistan.
Afr J Reprod Health. 2025;29. PubMed Abstract available
LAMANNA A, Gosselin S, Buick C Exploring the role of the oncology nurse in cervical cancer screening programs
during times of transition.
Can Oncol Nurs J. 2025;35:223-243. PubMed Abstract available
HYMAN J, Slatnik C, Ellwood M Cervical cancer treatment and nursing considerations: Best practices for
effective care.
Can Oncol Nurs J. 2025;35:244-263. PubMed Abstract available
SMALLEY TB, Nicolaci AA, Tran KC, Lokhandwala J, et al Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical
cancer.
Mol Ther. 2025 Aug 26:S1525-0016(25)00663-X. doi: 10.1016/j.ymthe.2025. PubMed Abstract available
SORBYE S, Falang BM, Antonsen M, Mortensen E, et al Genotype-Specific HPV mRNA Triage Improves CIN2+ Detection Efficiency Compared to
Cytology: A Population-Based Study of HPV DNA-Positive Women.
Pathogens. 2025;14:749. PubMed Abstract available
GUNASEKARAN P, Shin SC, Hwang YS, Lee J, et al N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for
Cervical Cancer.
Pharmaceutics. 2025;17:1027. PubMed Abstract available
SAVELIEV GM, Ciuvica AI, Cretoiu D, Varlas VN, et al Screening for Cervical Cancer and Early Treatment (SCCET) Project-The
Programmatic Data of Romanian Experience in Primary Screening for High-Risk HPV
DNA.
Diagnostics (Basel). 2025;15:2066. PubMed Abstract available
LEE SM, Seo H, Kim S, Cho HW, et al The Value of the Naples Prognostic Score at Diagnosis as a Predictor of Cervical
Cancer Progression.
Medicina (Kaunas). 2025;61:1381. PubMed Abstract available
SHEN-GUNTHER J, Xia Q, Cai H, Wang Y, et al Cervicovaginal Microbiome and HPV: A Standardized Approach to 16S/ITS NGS and
Microbial Community Profiling for Viral Association.
Int J Mol Sci. 2025;26:8090. PubMed Abstract available
SEINO R, Fukunaga H Deep Learning-Based Imaging Analysis Reveals Radiation-Induced Bystander Effects
on Cancer Cell Migration and the Modulation by Cisplatin.
Int J Mol Sci. 2025;26:7822. PubMed Abstract available
HUANG S, Yang R, Yang L, Kong S, et al Early Non-Response to Neoadjuvant Chemotherapy Will Increase the Recurrence of
Cervical Cancer: A Systematic Review.
Biomedicines. 2025;13:2016. PubMed Abstract available
MOCANU A, Ujica MA, Horovitz O, Tomoaia G, et al Enhanced Stability of Multi-Functionalized Gold Nanoparticles and Potential
Anticancer Efficacy on Human Cervical Cancer Cells.
Biomedicines. 2025;13:1861. PubMed Abstract available
ORIPOVA M, Abduvaliyeva MM Cervical teratoblastoma in a paediatric patient: clinical presentation and
management.
BMJ Case Rep. 2025;18:e265218. PubMed Abstract available
NDEKE JM, Rosenberg M, Yeates KE, Landsittel D, et al The relationship between rural residence and cervical cancer screening in three
sub-Saharan countries with different national screening policies.
BMJ Glob Health. 2025;10:e018634. PubMed Abstract available
LI X, Zheng J, Liu C, Liu B, et al Multidimensional technological advances in cervical cancer screening: From
standardized processes to precision medicine.
Biochim Biophys Acta Rev Cancer. 2025;1880:189432. PubMed Abstract available
ROBERGE-MALTAIS E, Levesque E, Castonguay V, Marcoux N, et al Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and
Cytokine Release Syndromes: A Case Report.
Curr Oncol. 2025;32:469. PubMed Abstract available
ZOU J, Xu JY, Hua XP, Cao Z, et al Knowledge of cervical cancer prevention and HPV vaccination: A survey among 961
college students in Hangzhou, China.
Medicine (Baltimore). 2025;104:e44069. PubMed Abstract available
ZHANG R, Kong J, Li Y, Wang H, et al Risk of cervical squamous cell carcinoma associated with a single nucleotide
polymorphism in the RAD18 gene in the Chinese population and its significance as
a predictive biomarker.
Medicine (Baltimore). 2025;104:e44017. PubMed Abstract available
RANI H, Ganai SA, Mahadevan V Histone Deacetylase Inhibitors orchestrate epigenetic signalling and alter the
nucleoporins and nuclear envelope in cervical cancer.
Transl Oncol. 2025;61:102510. PubMed Abstract available
LUIZAGA CTM, Camara AB, Cury LCPB, Lopez RVM, et al Barriers and attitudes toward cervical cancer screening among eligible women.
Cancer Causes Control. 2025 Aug 27. doi: 10.1007/s10552-025-02058. PubMed Abstract available
XU C, Xu Y, Wang G Bibliometric analysis of research on cervical cancer and miRNAs from 2010 to
2024: research trends, hotspots, and prospects.
Discov Oncol. 2025;16:1639. PubMed Abstract available
RIBEIRO CM, Claro IB, Tomazelli JG, Dias MBK, et al [Cervical cancer screening in Brazil: a coverage analysis using the Brazilian
Cancer Information System].
Cad Saude Publica. 2025;41:e00152224. PubMed Abstract available
FATTORE GL, Araoz Olivos N, Leveau CM, Ballejo C, et al [Spatial and spatiotemporal inequalities in premature mortality due to cervical
cancer in Argentina (2001-2020)Desigualdades espaciais e espaco-temporais na
mortalidade prematura por cancer do colo do utero na Argentina (2001-2020)].
Rev Panam Salud Publica. 2025;49:e90. PubMed Abstract available
ZHANG F, Ma Z, Zhang F, Li Y, et al Serous and Exosomal LDH-C4 as a Potential Diagnostic and Prognostic Biomarker of
Cervical Carcinoma.
Iran J Med Sci. 2025;50:539-547. PubMed Abstract available
MISHRA E, Chaudhary E, Mishra S, Rawat V, et al Cervical Cancer Screening Using Papanicolaou Smear and Visual Inspection With
Acetic Acid and Their Correlation With Colposcopy.
Cureus. 2025;17:e88679. PubMed Abstract available
AMUZIE CI, Bassi AP, Fishman E, Mekonnen D, et al Parental acceptance of human papillomavirus vaccine for female adolescents in
Abia State, southeastern Nigeria: a pre-implementation study.
Pan Afr Med J. 2025;51:44. PubMed Abstract available
EKINU J, Ayikobua ET, Icodu E, Akurut H, et al Factors Associated with Cervical Cancer Screening Uptake Among Women Attending
Outpatient Department in a Rural District Hospital in Uganda. A Cross-Sectional
Study.
Int J Womens Health. 2025;17:2603-2611. PubMed Abstract available
WANG Z, Xiao Y, Chen R, Tang E, et al From Mechanisms to Therapy: Exploring the Role of Ferroptosis in Cervical Cancer
Transformation and Treatment.
Traffic. 2025;26. PubMed Abstract available
LUNDGREN JG, Flynn MG, List K The cell-surface serine protease prostasin is lost during cervical squamous cell
carcinogenesis.
Hum Cell. 2025;38:147. PubMed Abstract available
ZHANG F, Chen X, Chu C, Chen M, et al FEN1 plays a key role in the transition from HSIL to CSCC.
Sci Rep. 2025;15:30122. PubMed Abstract available
BITAR H, Alismail S Toward an Understanding of the Lack of Transmission of Facts About Human
Papillomavirus: Qualitative Case Study.
JMIR Cancer. 2025;11:e64183. PubMed Abstract available
TORRISI M, Casigliani V, Mammolenti E, Porretta A, et al Inequalities in HPV vaccine offer among Italian regions: Analysis of regional
prevention plans.
Hum Vaccin Immunother. 2025;21:2546196. PubMed Abstract available
NKWINIKA VV, Amissah KA, Rakgole JN, Khaba MC, et al APTIMA mRNA vs. DNA-Based HPV Assays: Analytical Performance Insights from a
Resource-Limited South African Setting.
Int J Mol Sci. 2025;26:7450. PubMed Abstract available
POWELL A, Anderson L, Brotherton JML, Butler T, et al Cervical screening approach of self-collection, point-of-care HPV testing, and
same-day colposcopy among Aboriginal and Torres Strait Islander women in remote
Western Australia (the PREVENT Project): an implementation study.
Lancet Public Health. 2025;10:e732-e740. PubMed Abstract available
LIU T, Wen S, Wang S, Liang R, et al Deep learning-based automatic dose optimization for brachytherapy.
Appl Radiat Isot. 2025;225:111988. PubMed Abstract available
ROUX K, Roux F, Burns S, Guy R, et al Effective strategies in human papillomavirus (HPV) vaccination interventions to
increase uptake in rural, low socioeconomic, indigenous and migrant populations:
A scoping review.
Vaccine. 2025;61:127359. PubMed Abstract available
OKO-OBOH GA, Auvinen A, Obaseki DE, Pitkaniemi J, et al Method of detection, determinants and subsequent treatments for breast, cervical
and prostate cancers in Edo-Benin, Nigeria.
Cancer Causes Control. 2025;36:947-956. PubMed Abstract available
KRIEGER N, Moallef S, Cowger TL, Chen JT, et al Political determinants of US states' screening-amenable cancer stage at diagnosis
and premature cancer mortality.
JNCI Cancer Spectr. 2025;9:pkaf073. PubMed Abstract available
BIBER W, Fras M, Ciechacka M, Al-Jeabory M, et al Adaptation to cancer among Polish patients with cervical cancer in relation to
illness acceptance, life satisfaction, and dispositional optimism.
Ginekol Pol. 2025 Sep 5. doi: 10.5603/gpl.108039. PubMed Abstract available
ASWANI A, Butt E, Akinooye O, Chokapirat C, et al Navigating Cervical Cancer Risk in a Patient With Classic Congenital Adrenal
Hyperplasia (CAH): A Case Report.
Cureus. 2025;17:e89331. PubMed Abstract available
WANG Y, Lu Q, Na J, Wang X, et al Safety and efficacy of radical hysterectomy based on embryo
development-originated in the treatment of early cervical cancer: a single-arm
meta-analysis.
J Gynecol Oncol. 2025 Aug 25. doi: 10.3802/jgo.2026. PubMed Abstract available
YANAZUME S, Kitazono I, Togami S, Tanimoto A, et al Potential biomarkers for predicting the efficacy of a pembrolizumab-containing
regimen in advanced cervical cancer: A real-world analysis.
Turk J Obstet Gynecol. 2025;22:246-256. PubMed Abstract available
GULER CEKIC S, Bulut M, Aldikactioglu Talmac M, Aydin E, et al Risk factors for parametrial invasion in early-stage cervical cancer: Toward less
radical surgery.
Turk J Obstet Gynecol. 2025;22:237-245. PubMed Abstract available
VAN WIETMARSCHEN HA, Area-Gomez E, Picard M, Goodheart MJ, et al Metabolic Effects of Healing Touch During Cervical Cancer Treatment: An
Exploratory Analysis.
Integr Cancer Ther. 2025;24:15347354251367793. PubMed Abstract available
ZOU D, Wu X, Xin X, Xu T, et al Construction and Validation of a Novel Prognostic Model Based on Cervical
Cancer-Related Genes.
Reprod Sci. 2025 Sep 4. doi: 10.1007/s43032-025-01973. PubMed Abstract available
QUAYSON H, Bonney JHK, Sam D, Nuer-Allornuvor GF, et al Expression patterns of plasma microRNAs in patients with cervical cancer from two
teaching hospitals in Ghana.
J Cancer Res Clin Oncol. 2025;151:242. PubMed Abstract available
SHEN J, Zhang D, Zheng Q, Zhang Z, et al ClC-3 inhibition induces autophagy to reverse cisplatin resistance in cervical
cancer via the Akt/mTOR pathway.
Biochim Biophys Acta Mol Basis Dis. 2025 Sep 2:168030. PubMed Abstract available
HSIN MC, Wang PH, Chen PN, Hsieh YH, et al S100A16 knockdown reduces RPN2 expression and inhibits beta-catenin/TCF signaling,
leading to suppressed metastasis in cervical cancer cells.
Biochim Biophys Acta Mol Cell Res. 2025;1872:120053. PubMed Abstract available
BAE S, Kang YJ, Ahn J, Jang BH, et al Socioeconomic factors affecting breast and cervical cancer screening compliance
in Asian National Cancer Centers Alliance countries: a systematic review.
Epidemiol Health. 2025 Aug 28:e2025050. doi: 10.4178/epih.e2025050. PubMed Abstract available
GAN G Response to Letter Regarding 'Feasibility Study of an Efficient Plan Pool
Adaptive Radiotherapy Technology Based on Low-Dose Computed Tomography for
Cervical Cancer'.
Clin Oncol (R Coll Radiol). 2025;46:103922. PubMed
SADANA A, Omoto J, Sorgi K, Rahangdale L, et al Feasibility of Intravaginal Artesunate as an Adjuvant HPV & Cervical Precancer
Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II
Clinical Trial.
Cancer Control. 2025;32:10732748251374418. PubMed Abstract available
MACINAS DV JR, Tantengco OAG, de Paz-Silava SLM, Kammala AK, et al Comparative Analysis of Vaginal Inflammatory Cytokines Among HPV-Positive and
HPV-Negative Women in Manila, Philippines.
Am J Reprod Immunol. 2025;94:e70148. PubMed Abstract available
ZHOU L, Bai Y, Diao P, Zeng S, et al Comparison of postoperative adjuvant therapy for early-stage cervical cancer: A
surveillance, epidemiology, and end results analysis.
J Cancer Res Ther. 2025;21:834-841. PubMed Abstract available
YANG G, Mo Y, Rong H, Guo B, et al Caulerpin suppresses tumor-associated angiogenesis and tumor growth via Hippo
signaling in cervical cancer.
Toxicol Appl Pharmacol. 2025;504:117541. PubMed Abstract available
JIA Y, Zhang F, Zou K, Zou L, et al A clinical study on the efficacy of concurrent chemoradiotherapy combined with
targeted therapy and hyperthermia in patients with locally advanced cervical
cancer.
Transl Oncol. 2025;61:102516. PubMed Abstract available
FERNANDES S, Mashharawi N, Bhutta AE, Varghese RM, et al Comparison of Self-Collected Versus Clinician-Collected Human Papillomavirus
(HPV) Sampling for Cervical Cancer Screening: A Pilot Study in the United Arab
Emirates.
Cureus. 2025;17:e89250. PubMed Abstract available
OBEAGU EI Anemia and hematocrit decline in cervical cancer: unveiling clinical consequences
and management strategies.
Ann Med Surg (Lond). 2025;87:5784-5791. PubMed Abstract available
FUADY A, Kasempa C, Lucas E, Nyambe N, et al Economic evaluation of thermal ablation compared to cryotherapy and loop
diathermy in a screen-and-treat approach to cervical cancer, Zambia.
Bull World Health Organ. 2025;103:530-540. PubMed Abstract available
NIU S, Zhang L, Wang L, Zhang X, et al Hybrid feature fusion in cervical cancer cytology: a novel dual-module approach
framework for lesion detection and classification using radiomics, deep learning,
and reproducibility.
Front Oncol. 2025;15:1595980. PubMed Abstract available
MIGOWSKI A Past, present, and future of screening for cervical cancer in Brazil: lessons
learned?
Cad Saude Publica. 2025;41:e00134625. PubMed
ROSAS-MENDOZA MA, Santos-Rosales YR, Chilipio-Chiclla MA Frequency and factors associated with the preference for self-testing for human
papillomavirus detection.
Rev Peru Med Exp Salud Publica. 2025;42:166-174. PubMed Abstract available
MARI NL, Souza MVF, Meirelles LEF, Carvalho ARBA, et al Chrysin induces cell death and inhibits migration and invasion in squamous
cervical carcinoma using a three-dimensional cell culture model.
Braz J Med Biol Res. 2025;58:e14692. PubMed Abstract available
BALAJEWICZ-NOWAK M, Kabzinska-Turek M, Kosiawa V Association between cervical intraepithelial neoplasia progression and
cervicovaginal microbiota status - narrative review.
Folia Med Cracov. 2024;64:15-21. PubMed Abstract available
DAS S, Sahay MR, Singh AK, Roy P, et al Integrating Cervical Cancer Screening and Human Immunodeficiency Virus Care among
Women Living with Human Immunodeficiency Virus: A Call for Action.
Indian J Public Health. 2025;69. PubMed Abstract available
OPITO R, Lacika JL, Wabinga H, Orach CG, et al Symptom attributions by cervical cancer patients attending specialized care at
the Uganda cancer institute: a cross-sectional study.
Cancer Causes Control. 2025 Sep 2. doi: 10.1007/s10552-025-02062. PubMed Abstract available
BANJER HJ, Tayeb HH, Alzahrani KJ, Alsufiani SM, et al Cervical cancer risk and high-risk HPV types distribution in Saudi Arabia: Trends
from a national laboratory-based study.
Saudi Med J. 2025;46:992-999. PubMed Abstract available
DANKULCHAI P, Prasartseree T, Sittiwong W, Thephamongkhol K, et al Early Results of Hypofractionated Chemoradiation in Cervical Cancer with 44 Gy/
20 F vs 45 Gy/ 25 F: A Phase II, Open-Label, Randomised Controlled Trial
(HYPOCx-iRex Trial).
Clin Oncol (R Coll Radiol). 2025;46:103907. PubMed Abstract available
R A, Prasad S A blockchain-enabled healthcare system for cervical cancer risk prediction using
enhanced metaheuristic optimised graph convolutional attention based GRU.
MethodsX. 2025;15:103564. PubMed Abstract available
ALIKHANZADEH M, Imanparast A, Einafshar E, Gholamhosseinian H, et al Evaluation of Cherenkov-induced photodynamic therapy of biohybrid photosensitive
graphene oxide nanoplatform in cervical cancer cells.
Iran J Basic Med Sci. 2025;28:1392-1405. PubMed Abstract available
KULAL S, H K J, Shivapura Anandakumar A, H R R, et al The Sociocultural Determinants of Cervical Cancer Outcomes in India: A Critical
Review of Diagnostic Delays and Treatment Disparities.
Cureus. 2025;17:e88967. PubMed Abstract available
LI L, Bo Y, Xue D, Qin L, et al Ferroptosis-immune crosstalk in cervical cancer: mechanisms and therapeutic
implications.
Front Immunol. 2025;16:1657905. PubMed Abstract available
OGUNSOLA O, Gaydos LM, Ajayi O, Dieci M, et al The CHESS Protocol: A Mixed-Methods Evaluation of an HPV Screening Intervention
for Women Living With HIV in Nigeria.
Int J Public Health. 2025;70:1608716. PubMed Abstract available
BARCENA BARBEIRA P, Paolino M, Binder F, Almonte M, et al Implementation of second round of HPV-based screening for cervical cancer in
programmatic contexts in Argentina.
Rev Panam Salud Publica. 2025;49:e92. PubMed Abstract available
TOFFAHA K, Simsekler MCE, Sleptchenko A, Kortt MA, et al A Machine Learning and Bayesian Belief Network Approach to Predicting Cervical
Cancer Risk: Implications for Risk Management.
J Multidiscip Healthc. 2025;18:5199-5211. PubMed Abstract available
SAVELIEV GM, Varlas VN, Piron-Dumitrascu M, Suciu N, et al Cervical cancer screening in Europe and Romania: a review of policies, progress,
and persistent disparities.
J Med Life. 2025;18:604-607. PubMed Abstract available
JEMANE KC, Kuyu MB, Tegenaw GS Developing multimodal cervical cancer risk assessment and prediction model based
on LMIC hospital patient card sheets and histopathological images.
BMC Med Inform Decis Mak. 2025;25:322. PubMed Abstract available
ZHANG T, Ji T, Duan Z, Xue Y, et al Retraction Note: Long non-coding RNA MLLT4 antisense RNA 1 induces autophagy to
inhibit tumorigenesis of cervical cancer through modulating the myosin-9/ATG14
axis.
Sci Rep. 2025;15:32078. PubMed
MASAMBA MAKANANI C, Nyondo-Mipando AL, Jumbe V Barriers and strategies to enhance HPV vaccine uptake in adolescents living with
HIV and their guardians in Lilongwe, Malawi.
Sci Rep. 2025;15:32230. PubMed Abstract available
DE SOUSA C, Eksteen C, Engelbrecht AM Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and
Mitigating Metastasis.
Cancer Med. 2025;14:e71194. PubMed Abstract available
XI M, Wang X, Xu X, Zhang J, et al Predictive value of MHC-related genes in cervical cancer: implications for
immunotherapy and prognostic nomogram development.
Discov Oncol. 2025;16:1662. PubMed Abstract available
WANG Y, Li C MYB Activates the Hedgehog Signaling Pathway to Repress Natural Killer
Cytotoxicity in Cervical Cancer.
Kaohsiung J Med Sci. 2025 Sep 1:e70084. doi: 10.1002/kjm2.70084. PubMed Abstract available
ORANRATANAPHAN S, Moonchai K, Pohthipornthawat N, Santibenchakul S, et al Knowledge, attitudes and practices regarding cervical cancer screening among
women in the Dindaeng community, Bangkok, Thailand: a cross-sectional
community-based study.
BMJ Open. 2025;15:e100896. PubMed Abstract available
NISHA M, Bateson D, Saville M, Nightingale CE, et al The role of non-medical providers in increasing access to cervical screening: a
scoping review.
BMJ Glob Health. 2025;10:e019041. PubMed Abstract available
LI N, Zhou S, Zhang Y, Li R, et al Immunochromatographic assay for rapid detection of SIGLEC15 to evaluate its
therapeutic potential in cervical cancer.
Int J Biol Macromol. 2025;324. PubMed Abstract available
EMAGNENEH T, Mulugeta C, Ejigu B, Alamrew A, et al Uptake of cervical cancer screening and its associated factors in Africa: an
umbrella review of systematic reviews and meta-analyses.
BMC Public Health. 2025;25:2968. PubMed Abstract available
LIU Y, Li R, Du H, Wu R, et al HPV negative conversion following Hiporfin PDT for HPV associated HSIL in the
female lower reproductive tract.
Sci Rep. 2025;15:31973. PubMed Abstract available
NOGUEIRA CM, Reis BS, Meneses AFP, Mellado BH, et al Unveiling delays: understanding the diagnostic pathways of women
with advanced cervical cancer.
Support Care Cancer. 2025;33:826. PubMed Abstract available
PURDY NL, Katz ML, Reiter PL Women's acceptability of HPV self-collection in a healthcare setting following
FDA approval in the United States.
Women Health. 2025;65:606-617. PubMed Abstract available
SAINI S, Liu X Dendrite cross attention for high-dose-rate brachytherapy distribution planning.
Comput Biol Med. 2025;196. PubMed Abstract available
LAOHAWETWANIT T, Apornvirat S, Asaturova A, Li H, et al Evaluation of general-purpose large language models as diagnostic support tools
in cervical cytology.
Pathol Res Pract. 2025;274:156159. PubMed Abstract available
NI M, Wan D, Li M, Wu J, et al Deficiency of the UBE2C/F264 Axis Underlies Intrinsic Radioresistance in Cervical
Carcinoma.
J Proteome Res. 2025;24:4665-4673. PubMed Abstract available
PHILLIPS SA, Denoel S, Wentzensen N, Arbyn M, et al Accuracy of HPV Self-Collection Compared with Clinician-Collected HPV Testing and
Cytology: A Meta-analysis.
Cancer Epidemiol Biomarkers Prev. 2025;34:1467-1471. PubMed Abstract available
UYAR NY, Bodur H, Erdem MO, Altinisik IAK, et al Concentrated urine as an alternative to cervical smear samples enabling easy
screening of HPV in large populations.
J Infect Public Health. 2025;18:102857. PubMed Abstract available
GULSTENE S, Amjad R, Mendez LC Understanding the value of paracervical block during gynecologic brachytherapy: A
systematic review of the literature.
Brachytherapy. 2025;24:694-702. PubMed Abstract available
REN T, Qiu J, Chen F, Jiang Q, et al Targeting Glutamine Metabolism Transporter SLC25A22 Enhances CD8+ T-Cell Function
and Anti-PD-1 Therapy Efficacy in Cervical Squamous Cell Carcinoma: Integrated
Metabolomics, Transcriptomics and T-Cell-Incorporated Tumor Organoid Studies.
Adv Sci (Weinh). 2025;12:e02225. PubMed Abstract available
HUANG D, Baldandorj B, Odkhuu E, Amartuvshin E, et al ERO1alpha regulates curcumin-induced autophagy via PI3K/AKT pathway.
Cancer Treat Res Commun. 2025;44:100957. PubMed Abstract available
KAWAGUCHI R, Uchiyama T, Sugimoto S, Kamibayashi J, et al Tissue Factor Pathway Inhibitor-2 Expression in Uterine Cervical Clear Cell
Carcinoma: A Potential Biomarker for Clinical Diagnosis.
Appl Immunohistochem Mol Morphol. 2025;33:315-320. PubMed Abstract available
KUETE LT, Glennon A, Ptashnik S, Schickel M, et al Interstitial cervical needle-guide ring-cap prototype for patient-specific
ring-and-tandem brachytherapy.
Brachytherapy. 2025;24:703-710. PubMed Abstract available
CHONG L, Zou Z, Xia L, Wang X, et al p16 expression and its correlation with the clinical pathological characteristics
of patients with cervical cancer: a systematic review and meta-analysis.
BMJ Open. 2025;15:e102602. PubMed Abstract available
JIANG H, Chen X Vulvar cancer combined with cervical cancer.
J Obstet Gynaecol Can. 2025 Sep 10:103105. doi: 10.1016/j.jogc.2025.103105. PubMed
AN S, Han A, Lin Z, Quan H, et al Targeting ferroptosis in cervical cancer: Mechanistic insights and therapeutic
opportunities.
Cell Signal. 2025 Sep 10:112122. doi: 10.1016/j.cellsig.2025.112122. PubMed Abstract available
LI S, Guo C, Fang Y, Qiu J, et al Machine Learning for Preoperative Assessment and Postoperative Prediction in
Cervical Cancer: Multicenter Retrospective Model Integrating MRI and
Clinicopathological Data.
JMIR Cancer. 2025;11:e69057. PubMed Abstract available
AUTORINO R, Macchia G, Russo L, Dinapoli N, et al Which is the best timing to assess response after chemoradiation in locally
advanced cervical cancer (BRILACC)?
Strahlenther Onkol. 2025 Sep 12. doi: 10.1007/s00066-025-02463. PubMed Abstract available
WANG W, Deng Y, Feng Y, Chen R, et al Unveiling Gamma-Interferon-Inducible Lysosomal Thiol Reductase (IFI30) as a
Regulator of Macrophage Polarization and Prognostic Biomarker by
Multi-Transcriptome Analysis in Cervical Cancer.
IUBMB Life. 2025;77:e70056. PubMed Abstract available
LI Z, Wang H, Yang R, Jin X, et al Plasma-Derived Exosomal tRF-Phe-GAA-001 and tRF-Gly-GCC-037 as Novel Diagnostic
Biomarkers for Cervical Cancer.
Indian J Clin Biochem. 2025;40:683-690. PubMed Abstract available
YADAV J, Gupta S, Venugopal AK, Ghosh A, et al 3D Conformal Radiotherapy Versus the Conventional Box Technique for Cervical
Cancer: A Dosimetric Observational Study.
Cureus. 2025;17:e89799. PubMed Abstract available
SHI P, Zhang W, Yao Q, Yuan Z, et al CS Ratio is an immune-related prognostic biomarker for cervical cancer.
Front Oncol. 2025;15:1547529. PubMed Abstract available
WANG X, Wang C, Zong D, Zhu B, et al First-line treatment with cadonilimab plus paclitaxel-platinum +/- bevacizumab for
persistent, recurrent, or metastatic cervical cancer: a retrospective real-world
study.
Front Oncol. 2025;15:1634779. PubMed Abstract available
XIE C, Liu H, Huang D, Zhao G, et al Case Report: Cervical cancer masquerading as ovarian tumor: diagnostic challenges
in a case with severe pyometra-pyocolpos complex.
Front Oncol. 2025;15:1647366. PubMed Abstract available
DUAN S, Su Y, Niu Q, Wei J, et al Construction and implementation of a nursing intervention program based on
supportive care theory for cervical cancer patients receiving postoperative
concurrent chemoradiotherapy.
Support Care Cancer. 2025;33:845. PubMed Abstract available
ATLAS SJ, Burdick TE, Wright A, Zhao W, et al Comparing clinical decision support systems for improving follow-up of abnormal
cervical cancer screening test results.
J Biomed Inform. 2025 Sep 9:104908. doi: 10.1016/j.jbi.2025.104908. PubMed Abstract available
DAMGACIOGLU H, Curtis C, Sonawane K, Clifford G, et al Anal Cancer Incidence Among Women With a History of Cervical Cancer by Age and
Time Since Diagnosis.
JAMA Netw Open. 2025;8:e2531362. PubMed
HAO Y, Liu Q, Wang B, Zhang W, et al Proteomics-Based Mapping of the Lymph Node Metastasis Landscape in Cervical
Cancer.
J Proteome Res. 2025 Sep 11. doi: 10.1021/acs.jproteome.5c00570. PubMed Abstract available
CHEN R, Ye C, Li Y, Lin Z, et al Analysis of follow-up outcomes in patients with cervical histologic low-grade
squamous intraepithelial lesion preceded by serious cytology and repeated
diagnosis for at least 2 years.
Womens Health (Lond). 2025;21:17455057251374504. PubMed Abstract available
TIAN M, Yuan Z, Wang H, Liu T, et al The cachexia index as a prognostic indicator in patients with cervical cancer
treated with radiotherapy: A retrospective study.
Nutr Clin Pract. 2025 Sep 10. doi: 10.1002/ncp.70032. PubMed Abstract available
CHONA EZ, Gosse RA, Msengi EA, Aruldhas TP, et al Life Experiences of Women Diagnosed With Cervical Cancer in Sub-Saharan Africa: A
Systematic Review of Qualitative Studies.
Psychooncology. 2025;34:e70280. PubMed Abstract available
ZHU H, Zhu H, Bao Y Multiple injections of indocyanine green for improving the outcomes of
lymphatic-venous anastomosis reconstruction of lymphatic return under microscopy:
A case report.
J Int Med Res. 2025;53:3000605251375258. PubMed Abstract available
HUA J, Klein WMP, Acevedo AM Sociocultural correlates of cervical cancer prevention behaviors among
Hispanic/Latina women in the United States.
Ann Behav Med. 2025;59:kaaf069. PubMed Abstract available
HRYNEVYCH OY Human papillomavirus: problems and prospects for women's reproductive health
(systematic review).
Pol Merkur Lekarski. 2025;53:546-554. PubMed Abstract available
FREITAS AKMSO, Camargo JDAS, Souza ATB, Pontes THA, et al Sociodemographic and clinical factors associated with delayed diagnosis of
cervical cancer: a cross-sectional study, Brazil, 2016-2020.
Epidemiol Serv Saude. 2025;34:e20240764. PubMed Abstract available
VIEIRA JR, Azize R, Nucci MF [Between gender and health technologies: an analysis of HPV and cervical cancer
prevention campaigns from 2014 to 2020].
Cien Saude Colet. 2025;30:e04072024. PubMed Abstract available
BILALAGA MM, Gaddipati G, Devkota A, Vasireddy R, et al HPV knowledge and non-adherence to cervical cancer screening before and following
the COVID-19 pandemic in the United States.
PLOS Glob Public Health. 2025;5:e0004800. PubMed Abstract available
REN X, Wu J, Yang S, Wang Y, et al Radiotherapy-Related Bladder Fistula: A Hidden Cause of Recurrent Abdominal
Symptoms.
Am J Case Rep. 2025;26:e948953. PubMed Abstract available
LI Y, Cai L, Zhou J, Zhang X, et al RCN1 Binds KIF14 and Promotes the Malignant Growth of Cervical Cancer Through the
PI3K-AKT Pathway.
Int J Gen Med. 2025;18:5047-5062. PubMed Abstract available
DONG Y, Zhang X, Zhao J, Hou Q, et al Glycan dysregulation as one of major metabolic subtypes is associated with TERC
overexpression and poor outcomes in cervical cancer.
Front Immunol. 2025;16:1585647. PubMed Abstract available
DE OLIVEIRA SERRA TOCHETTO L, Meimei Brevidelli M, Rodrigues Santos T, Samora de Almeida M, et al Quality of cervical cancer screening in a Brazilian sample: cross-sectional
study.
Rev Cuid. 2025;16:e3597. PubMed Abstract available
OLSON A, Fuzzell L, Brownstein NC, Fontenot HB, et al Factors Associated With Guideline-Concordant Cervical Cancer Screening Exit: A
Mixed Methods Study.
Womens Health Issues. 2025 Sep 8:S1049-3867(25)00102. PubMed Abstract available
OKUNADE KS, Fayinto AI, Adekanye TV, Allsop MJ, et al Randomized Controlled Trial of Impact of Mobile Health Technologies on Human
Papillomavirus Vaccination Uptake in Mothers of Vaccine-Eligible Girls in Lagos,
Nigeria (mHealth-HPVac).
JCO Glob Oncol. 2025;11:e2500150. PubMed Abstract available
ADHIAMBO HF, Owidi E, Okello P, Coe M, et al Barriers and facilitators to implementing a single-visit, screen-and-treat
approach with thermal ablation for cervical cancer prevention in Kenya.
PLOS Glob Public Health. 2025;5:e0005166. PubMed Abstract available
YUAN J, Wang IT, Lin YH, Qiu JT, et al Two Cases of Primary Melanoma of the Uterine Cervix.
Am J Case Rep. 2025;26:e948101. PubMed Abstract available
M EL-DOUSHY A, Attalla EM, Ibrahim IH, El-Sayed SM, et al Dosimetry evaluation and uncertainty analysis of Cobalt-60 HDR brachytherapy for
cervical cancer in resource-limited settings.
J Cancer Res Clin Oncol. 2025;151:247. PubMed Abstract available
FU X, Zhang Q, Wagner AL, Zhou W, et al Cost-effectiveness and epidemiological impact of gender-neutral vaccination
against human papillomavirus in economically developed metropolises of Beijing,
Shanghai, and Guangzhou, China.
Hum Vaccin Immunother. 2025;21:2557092. PubMed Abstract available
POLANE MG, Dlamini SB Exploring primary health care nurses' perceptions of cervical cancer screening in
Leribe, Lesotho.
Afr J Prim Health Care Fam Med. 2025;17:e1-e9. PubMed Abstract available
NDAKUKAMO EK, Mahalie R, Hailonga-van Dijk P Health system constraints in cervical cancer prevention in rural Namibia: A
qualitative study.
Afr J Prim Health Care Fam Med. 2025;17:e1-e9. PubMed Abstract available
CHEN Z, Zhang L, Li D, Zhu R, et al Treatment of advanced cervical cancer with Cinobufacini and Paclitaxel-Cisplatin
combination: A meta-analysis.
Medicine (Baltimore). 2025;104:e44146. PubMed Abstract available
LEMA TF, Mosalo A, Moleki M Perceived risk of human papillomavirus infection and cervical cancer: a
qualitative study among Ethiopian women.
BMJ Open. 2025;15:e103895. PubMed Abstract available
CELA M, Gjata E, Sinaj E, Ndreu V, et al The influence of parents' knowledge on HPV vaccine uptake - evidence from
Albania.
J Infect Dev Ctries. 2025;19:1231-1238. PubMed Abstract available
HARPER DM, Anderson PF, James LN, Alves M, et al A Scoping Review of Women with Physical Disabilities and Cervical Cancer
Screening.
J Womens Health (Larchmt). 2025 Sep 8. doi: 10.1177/15409996251374587. PubMed Abstract available
ZANWAR PP Cervical Cancer Screening: Perspectives from an Interdisciplinary Lens to Inform
Future Research, Practice, Policy, and Intervention Strategies.
J Womens Health (Larchmt). 2025 Sep 8. doi: 10.1177/15409996251370876. PubMed
KAPP P, Schmucker C, Siemens W, Brugger T, et al Human papillomavirus (HPV) vaccination in women with conisation.
Cochrane Database Syst Rev. 2025;9:CD016121. PubMed Abstract available
PATRE P, Verma D Deep dive into deep learning methods for cervical cancer detection and
classification.
Rep Pract Oncol Radiother. 2025;30:396-416. PubMed Abstract available
PATRE P, Verma D Optimizing cervical cancer diagnosis with accurate cell classification using
modified HDFF.
Rep Pract Oncol Radiother. 2025;30:316-331. PubMed Abstract available
LIU C, Li X, Deng Y Case Report: Immune-mediated acute liver failure induced by tislelizumab in a
patient with advanced cervical cancer.
Front Oncol. 2025;15:1604601. PubMed Abstract available
CUI N, Zhang Y, Zhang Y, Wang L, et al TRIM31 acts as an intermediate molecule in the process by which Snai2 impairs the
proliferation of cervical cancer cells.
Front Oncol. 2025;15:1537991. PubMed Abstract available
VERMA R, Sharma R, Mishra P, Mishra N, et al Opportunistic Cervical Cancer Screening During Antenatal Visits: A Small Step
Toward Early Detection.
Cureus. 2025;17:e89433. PubMed Abstract available
WU J, Xu Q, Huang H, Pang Y, et al Risk and prognosis for brain metastasis in primary metastatic cervical cancer
patients: A population-based study.
Open Med (Wars). 2025;20:20251165. PubMed Abstract available
REN L, Zhang J, Yang J, Ji L, et al YTHDC2 inhibits HPV-positive cervical cancer growth by suppressing SLC7A11 in a
ferroptosis-dependent manner.
Oncol Lett. 2025;30:498. PubMed Abstract available
ZOGHEBI K, Jali AM Flavonoids as Dual Inhibitors of MELK and LYN Kinases in Cervical Cancer: An In
Silico Molecular Docking Analysis.
Curr Pharm Des. 2025 Sep 5. doi: 10.2174/0113816128387273250823102532. PubMed Abstract available
LI YM, Zhao QL, Ogawa R, Mizukami T, et al Synergistic inhibition of autophagic flux and induction of apoptosis in cervical
cancer cells by Mito-TEMPO and hyperthermia.
Environ Health Prev Med. 2025;30:67. PubMed Abstract available
KOMORI S, Takagawa Y, Sato H, Machida M, et al A novel dose-based intra-preplan method for high-dose-rate brachytherapy in
cervical cancer using modeling and optimization algorithms.
Brachytherapy. 2025 Sep 6:S1538-4721(25)00250. PubMed Abstract available
GAO Y, Zou T Hypoxia Triggers ALYREF-Mediated m(5)C Methylation of KIF20A to Activate
KIF20A/BUB1 for Generating Ferroptosis Resistance in Cervical Cancer Cells.
Kaohsiung J Med Sci. 2025 Sep 7:e70093. doi: 10.1002/kjm2.70093. PubMed Abstract available
BAKAN ABS, Aslan G, Basaran F An Investigation of the Effect of Education Interventions Given to Women in
Turkey with Religious Orientation on Cervical Cancer and Pap Smear Test Health
Beliefs.
J Relig Health. 2025 Sep 7. doi: 10.1007/s10943-025-02435. PubMed Abstract available
KHARE SK, Booth BB, Blanes-Vidal V, Petersen LK, et al An explainable attention model for cervical precancer risk classification using
colposcopic images.
Comput Methods Programs Biomed. 2025;271:108976. PubMed Abstract available
VAN COOTEN VV, van Hamont D, Siebers AG, Alcala L, et al The prevalence and clinical relevance of cervical abnormalities after an
amputation of the cervix as part of prolapse surgery: a cross-sectional study.
Arch Gynecol Obstet. 2025;312:1287-1294. PubMed Abstract available
DOXTADER EE, Ooms K, Brainard JA, Policarpio-Nicolas MLC, et al Papanicolaou test interpretation utilizing the Hologic Genius Digital Diagnostics
System vs manual glass slide review: A retrospective study of 596 cases.
Am J Clin Pathol. 2025;164:513-521. PubMed Abstract available
NIYOTEKA S, Rouhi R, Laurent PA, Achkar S, et al GAN-based standardization of MR images: a promising approach for the development
of multicentre radiomic models.
Phys Med Biol. 2025;70. PubMed Abstract available
EHLERS U, Hoischen L, Stalp JL, Hachenberg J, et al The treatment of cervical intraepithelial neoplasia grade 2 (HSIL): between
active surveillance and surgery-a 10-year monocentric data analysis.
Arch Gynecol Obstet. 2025;312:1125-1132. PubMed Abstract available
CEN Y, Tu M, Zhang Y, Ren Y, et al A novel non-invasive mRNA-lncRNA biomarker panel for accurate prediction of
cervical squamous cell carcinoma and adenocarcinoma.
J Gynecol Oncol. 2025;36:e81. PubMed Abstract available
LIN M, Zou Y, Yu L, Xiao H, et al An immunoassay based on polyHRP signal amplification for HPV16/18 E6 RNA
detection with anti-DNA-RNA hybrid antibody.
Anal Sci. 2025;41:1461-1471. PubMed Abstract available
MINCHEW LA Self-Blame Attribution: Concept Analysis and Application to HPV-Related Cancers.
J Christ Nurs. 2025;42:216-223. PubMed Abstract available
LI S, Chen P, Zhang J, Wang B, et al MBLEformer: Multi-Scale Bidirectional Lesion Enhancement Transformer for Cervical
Cancer Image Segmentation.
Curr Med Imaging. 2025 Sep 16. doi: 10.2174/0115734056357180250516022218. PubMed Abstract available
LE A, Smith LS, Wheeler SB, Giannone K, et al Implementing self-collection for primary human papillomavirus testing:
Perspectives on implications for federally qualified health center patient
populations.
Womens Health (Lond). 2025;21:17455057251362581. PubMed Abstract available
YANG Y, Li C, Jia S, Wang Y, et al [TruScreen Combined With High-Risk Human Papillomavirus Testing vs Thinprep
Cytology Test Combined With High-Risk Human Papillomavirus Testing for Cervical
Cancer Screening: A Comparative Clinical Study].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56:852-857. PubMed Abstract available
AFOLABI EK, Olaogun AAE Assessment of the Quality of Cervical Cancer Prevention Services in Southwest
Nigeria: A Cross-Sectional Study Using Donabedian's Quality Framework.
Cancer Control. 2025;32:10732748251333036. PubMed Abstract available
ARYASOMAYAJULA C, Xu MJ, Hui CB, Wong ML, et al Cancer control and toxicity results of chemoradiation for cervical cancer using a
three-fraction HDR brachytherapy boost.
Brachytherapy. 2025 Sep 16:S1538-4721(25)00285. PubMed Abstract available
OSTENFELD EB, Bjornholt SM, Sponholtz SE, Froding LP, et al Long-term lymphedema and quality of life following lymph node staging in early
cervical cancer: 3 years follow-up in the prospective multicenter SENTIREC CERVIX
study.
Am J Obstet Gynecol. 2025 Sep 15:S0002-9378(25)00674. PubMed Abstract available
BAYKEMAGN ND, Aweke MN, Mesfin A, Baffa LD, et al Identifying Predictors of Cervical Cancer Screening Uptake in Sub-Saharan Africa
Using Machine Learning: Cross-Sectional Study.
JMIR Public Health Surveill. 2025;11:e71677. PubMed Abstract available
YIN Z, Feng T, Xu Q, Dai W, et al Monitoring circulating cell-free HPV DNA in metastatic or recurrent cervical
cancer: clinical significance and treatment implications.
Elife. 2025;13:RP101887. PubMed Abstract available
POLTEN R, Kutle I, Stalp JL, Hachenberg J, et al Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and
cancer-associated fibroblasts.
Oncoimmunology. 2025;14:2556714. PubMed Abstract available
FAN J, Xiao W, Yan Z, Ouyang Q, et al Accuracy of AI chatbots in answering frequently asked questions on cervical
cancer.
Front Artif Intell. 2025;8:1655303. PubMed Abstract available
OKUMA Y, Ikeda Y, Kobayashi O, Kamata S, et al Development of immune radiotherapy with yttrium by targeting Frizzled homologue
10 (FZD10) in cervical cancer.
Gynecol Oncol Rep. 2025;59:101736. PubMed Abstract available
TAVAKOLIAN S, Atani ZR, Faghihloo E Assessing the Biological Markers of MiRNA-9 and 192 Expression Levels in Cervical
Cancer.
Adv Biomed Res. 2025;14:91. PubMed Abstract available
SUK R, Lin YY, Dilley S, Chandler R, et al Survival by Treatment Recommendation and Receipt Among Older Patients With
Early-Stage Cervical Cancer.
JAMA Netw Open. 2025;8:e2532206. PubMed Abstract available
LEFEUVRE C, De Pauw H, Dhollander N, Le Duc Banaszuk AS, et al Mailing vaginal or urine self-sampling kits versus conventional invitation
letters: a randomised trial to assess the effect on cervical cancer screening
attendance.
Cancer Epidemiol Biomarkers Prev. 2025. PubMed Abstract available
MEYER CM, Rankin K, Handler A, Barshop W, et al Well-Woman Visits and Cervical Cancer Screening at the Intersection of Sexual
Orientation and Race/Ethnicity Among Illinois Women.
LGBT Health. 2025 Sep 16. doi: 10.1177/23258292251379503. PubMed Abstract available
CHEN YP, Deng X, Wang Y, Zhu YW, et al [Practices and considerations on the free HPV vaccination program for eligible
girls in Zhejiang Province under the global initiative to accelerate cervical
cancer elimination].
Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:1495-1502. PubMed Abstract available
SOLIS-PONCE L, Stosic M, Curico G, Espetia S, et al Genotype distribution and molecular characterization of HPV in the Peruvian
amazon: insights into prevalence, lineage diversity, and viral integration.
Sci Rep. 2025;15:32535. PubMed Abstract available
YAMADA H, Yokoi A, Asano-Inami E, Kitagawa M, et al Establishment of KGAS, a cell line derived from gastric-type adenocarcinoma of
the uterine cervix.
Hum Cell. 2025;38:159. PubMed Abstract available
SUWANTAROJ J, Sripan P, Kallawicha K, Tso J, et al The Utilization of Human Papillomavirus Testing for Cervical Cancer Screening in
Thailand: A Comparison of Screening with and without Self-sampling Samples.
Asian Pac J Cancer Prev. 2025;26:3469-3475. PubMed Abstract available
NATHANIEL V B, Chandraguthi SG, Rao S, Lewis S, et al Feasibility Study of Using Kv-Cone Beam CT Images as Patient Specific Quality
Assurance Tool.
Asian Pac J Cancer Prev. 2025;26:3359-3368. PubMed Abstract available
PLUTHIKARMPAE N, Thongjit S Prevalence of Human Papillomavirus Infection in Nakhon Ratchasima, Northeastern
Thailand.
Asian Pac J Cancer Prev. 2025;26:3353-3358. PubMed Abstract available
MUNIZAR M, Ar Royan H, Yolanda F Barriers to Cervical Cancer Screening through Pap Smear Examination among Women
Attending the Gynecology Polyclinic at Dr. Zainoel Abidin General Hospital in
2024: A Cross-Sectional Study.
Asian Pac J Cancer Prev. 2025;26:3309-3317. PubMed Abstract available
DE SOUSA LR, Sousa EDLS, Palmeira ACDC, Palmeira MS, et al The Role of lncRNAs in the Epithelial-Mesenchymal Transition in Cervical Cancer:
A Narrative Review.
Asian Pac J Cancer Prev. 2025;26:3137-3143. PubMed Abstract available
SAVIRA M, Farniga A, Ilmiah Z, Rachmadina R, et al Genetic variations of the L2 gene in human papillomavirus (HPV) type 16 from
cervical cancer patients in Sumatra region, Indonesia.
Narra J. 2025;5:e1653. PubMed Abstract available
LI D, Yan B, Liao K, Huang J, et al Multi-omics modality completion and knowledge distillation for drug response
prediction in cervical cancer.
Front Oncol. 2025;15:1622600. PubMed Abstract available
HUANG M, Chen X, Lin X, Yang Y, et al Prediction Models of Microinvasive Cervical Cancer in High-Grade Squamous
Intraepithelial Lesion Treatment by Loop Electrosurgical Excision Procedure.
Risk Manag Healthc Policy. 2025;18:2921-2934. PubMed Abstract available
NACIRI M, Aouzah FE, El Ghanmi A, Ghazi B, et al BRCA mutation and multiple primary malignancies: a rare case of recurring
triple-negative breast cancer and cervical cancer.
Ecancermedicalscience. 2025;19:1939. PubMed Abstract available
RYU SY, Deng W, Albuquerque K, Koh WJ, et al Randomized Phase III Trial of Adjuvant Radiation versus Chemoradiation in
Intermediate-Risk, Early-stage Cervical Cancer following Radical Hysterectomy and
Lymphadenectomy: Results from NRG Oncology/GOG-263/KGOG1008.
Ann Oncol. 2025 Sep 12:S0923-7534(25)04700-3. doi: 10.1016/j.annonc.2025. PubMed Abstract available
LIAO ZY, Chen Y, OuYang Z Umbilical port site metastasis after laparoscopic radical hysterectomy for
cervical cancer.
J Obstet Gynaecol Can. 2025 Sep 12:103109. doi: 10.1016/j.jogc.2025.103109. PubMed
HABERSTICH M, Rodrigues M [Pembrolizumab with chemoradiotherapy in high risk locally advanced cervical
cancer].
Bull Cancer. 2025 Sep 12:S0007-4551(25)00379. PubMed
BESO DELGADO M, Castan Cameo S, Requena Menendez A, Ibanez Cabanell J, et al [Implementation of population-based self-sampling cervical cancer screening.
Pilot study in the Valencian Community].
Gac Sanit. 2025;39:102522. PubMed Abstract available
LI N, Yuan H, Yan W, Zhang MM, et al Discovery of an acridine-based fluorescent ligand for selectively targeting
mitochondrial G-quadruplexes DNA and triggering cervical cancer cell death.
Spectrochim Acta A Mol Biomol Spectrosc. 2025;346:126844. PubMed Abstract available
SZABO V, Varbiro S, Kalas N, Vida B, et al The Lymphocyte-to-Monocyte Ratio (LMR) as a Novel Biomarker for Cervical Cancer
Risk Stratification in Conization Patients.
J Clin Med. 2025;14:6057. PubMed Abstract available
BARBU MA, Ghigeanu M, Bahaa-Eddin S, Michire A, et al Impact of Chemoradiotherapy on Quality of Life in Cervical Cancer Patients: A
Prospective Cohort Study.
J Clin Med. 2025;14:6023. PubMed Abstract available
OZDEMIR I, Afsin Y, Tuncer MC, Ozturk S, et al Combined Hesperidin and Doxorubicin Treatment Induces Apoptosis and Modulates
Inflammatory Cytokines in HeLa Cervical Cancer Cells.
Int J Mol Sci. 2025;26:8753. PubMed Abstract available
BARTUSIK-AEBISHER D, Saad MA, Przygorzewska A, Woznicki P, et al Latest Nanoparticles to Modulate Hypoxic Microenvironment in Photodynamic Therapy
of Cervical Cancer: A Review of In Vivo Studies.
Int J Mol Sci. 2025;26:8503. PubMed Abstract available
BOLDEANU L, Assani MZ, Boldeanu MV, Silosi I, et al Cervical Cancer in the Era of HPV: Translating Molecular Mechanisms into
Preventive Public Health Action.
Int J Mol Sci. 2025;26:8463. PubMed Abstract available
APOORVA, Handa V, Batra S, Arora V, et al Deep Learning-Based DNA Methylation Detection in Cervical Cancer Using the
One-Hot Character Representation Technique.
Diagnostics (Basel). 2025;15:2263. PubMed Abstract available
IBIS K, Ilgin C, Suncak L, Akbas CK, et al Prognostic Significance of Nomogram and T-Score in Locally Advanced Cervical
Cancer Patients Treated with Curative Chemoradiotherapy and Image-Guided
Brachytherapy: A Single-Center Retrospective Study.
Diagnostics (Basel). 2025;15:2142. PubMed Abstract available
PASCA NM, Taut D, Pintea S, Baban AS, et al Emotional, Cognitive, and Social Factors Influencing Romanian Women's Intention
to Undergo Cervical Cancer Screening: A Mixed-Method Study.
Healthcare (Basel). 2025;13:2147. PubMed Abstract available
SHPENDI S, Norman P, Gibson-Miller J, Webster R, et al Cervical screening attendance in young women and people with a cervix: An
application of the COM-B model.
Br J Health Psychol. 2025;30:e70016. PubMed Abstract available
ZHU YW, Chen YP, Liang YX, Wang SY, et al [Comparative analysis of free HPV vaccination programs across countries with
different income levels worldwide: from implementation to evaluation].
Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:1503-1511. PubMed Abstract available
LI J, Zhao D, Zi T, Huang R, et al Evolving trends in HPV vaccination coverage among women aged 9-45 in Chengdu,
China: insights from 2017 to 2023.
Vaccine. 2025;62:127579. PubMed Abstract available
CARLTON JG, Pamba D, Ryan N, Olomi W, et al Facilitators and barriers to implementation of HPV vaccination in Tanzania: a
mixed-methods study exploring perspectives from national, subnational, and
community stakeholders, 2018-2023.
Vaccine. 2025;62:127560. PubMed Abstract available
TAO T, Ni Y, Shi N, Yang X, et al Human papillomavirus vaccination coverage and willingness among women in mainland
China: A meta-analysis based on the COM-B model.
Vaccine. 2025;62:127519. PubMed Abstract available
[Expert consensus on comprehensive prevention and control strategies for human
papillomavirus associated diseases].
Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:1362-1371. PubMed Abstract available
BAUSSANO I, Tenet V, Baghdasarova K, Harutyunyan Z, et al HPV burden in Armenia among unvaccinated women: a series of cross-sectional
population-based prevalence surveys.
Vaccine. 2025;62:127405. PubMed Abstract available
RADULOVIC MK, Ostrbenk A, Poljak M, Strojan-Flezar M, et al Human papillomavirus (HPV) genotyping and prognostic value of HPV E4 protein and
transcription factors NANOG and SOX11 in atypical p16 patchy squamous epithelium
of cervix.
Radiol Oncol. 2025;59:391-402. PubMed Abstract available
BOLLEN I, Bernhardt M, Thiesler T, Winterhagen FI, et al The prognostic value of adipokine receptors leptinR and adiponectinR1 in
obesity-inducible solid tumours.
Histol Histopathol. 2025;40:1577-1596. PubMed Abstract available
YAMAMOTO T, Okamura Y, Kato Y, Masui K, et al Suppressive role of fukutin on cell proliferation in uterine cervical carcinoma
in relation to Aurora-A kinase.
Histol Histopathol. 2025;40:1555-1568. PubMed Abstract available
BIANCHI M, Capasso M, Donizzetti AR, Caso D, et al Navigating women's cancer prevention: Two cross-sectional studies to investigate
psychosocial antecedents of cervical and breast cancer screening attendance.
J Health Psychol. 2025;30:2970-2983. PubMed Abstract available
FISHER S, Agenor M Socioeconomic Inequities in Pap Test Use Among Black Women in the United States:
An Intersectional Approach.
J Racial Ethn Health Disparities. 2025;12:3451-3459. PubMed Abstract available
JESUINO FWDR, Araujo Junior E, Badiglian-Filho L Comparison of high-grade human papillomavirus-induced cervical lesions between
human immunodeficiency virus-positive and human immunodeficiency virus-negative
women.
Rev Assoc Med Bras (1992). 2025;71:e20250214. PubMed Abstract available
SHAN Y, Cui Z, Yin G A Commentary on "Simplifying surgical criteria for early-stage cervical cancer:
prognostic equivalence of total vs. radical hysterectomy in a retrospective seer
cohort analysis".
Int J Surg. 2025 Sep 23. doi: 10.1097/JS9.0000000000003393. PubMed
WARD IL, Bermingham CR, Soldan K, Nafilyan V, et al Evaluating the effectiveness of the human papillomavirus vaccination programme in
England, using a regression discontinuity design.
Int J Epidemiol. 2025;54:dyaf156. PubMed Abstract available
KHOWAJA A, Beiji Z, Kui X CerviNet: A Novel Approach for Cervical Cancer Classification Using Pap-Smear
Images.
J Comput Biol. 2025 Sep 24. doi: 10.1177/15578666251379909. PubMed Abstract available
FUJII T, Taira Y, Flannelly G, Nishizawa H, et al Supporting the global reduction of cervical cancer: challenges in colposcopy
practice and training.
Front Oncol. 2025;15:1592050. PubMed Abstract available
MUPENZI C, Manirafasha EN, Gbadamosi MA Factors Associated with Cervical Cancer Screening among Women at Selected
District Hospital, Rwanda.
Rwanda J Med Health Sci. 2025;8:208-220. PubMed Abstract available
VAN DER BRUGGEN B, De Munnik S, Bosgraaf R, Ammerlaan H, et al A more personalized approach to cervical cancer screening for women with HIV.
AIDS Care. 2025 Sep 23:1-10. doi: 10.1080/09540121.2025.2560098. PubMed Abstract available
JI C, Wang Y, Jiang Y, Wang Y, et al Retraction Notice to Single-cell RNA-sequencing Analysis Reveals the Promoting
Role of the Hedgehog Pathway in Epithelial Cells during Cervical Cancer
Progression.
Curr Med Chem. 2025 Sep 23. doi: 10.2174/0929867332999250923165204. PubMed Abstract available
SONG HN, Ha IB, Jeong BK, Cho JM, et al Posttreatment squamous cell carcinoma antigen: A prognostic marker for patients
with advanced cervical cancer treated with bevacizumab-paclitaxel-cisplatin
therapy.
Medicine (Baltimore). 2025;104:e44673. PubMed Abstract available
MASEKO TN, Tsoka-Gwegweni JM, Dlamini X, Nkambule R, et al Barriers and Facilitators to Utilization of Cervical Cancer Screening Services in
Eswatini: A Scoping Review.
West Afr J Med. 2025;42:311-320. PubMed Abstract available
WOLSWINKEL JT, Zusterzeel PLM, Smits A, Siebers AG, et al Survival After Fertility-Sparing Surgery for Early-Stage Cervical Cancer Compared
With Nonsparing Surgery: A Nationwide Comparative Study.
JCO Oncol Pract. 2025 Sep 23:OP2500131. doi: 10.1200/OP-25-00131. PubMed Abstract available
WANG J, Zhang J, Yang K, Ghavidel BB, et al Enhancing auto-contouring with large language model in high-dose rate
brachytherapy for cervical cancers.
Med Phys. 2025;52:e70034. PubMed Abstract available
WANG H, Sidike D, Liu P, Suo L, et al miR-129-5p regulates HMGB1/RAGE axis to inhibit pyroptosis and ameliorate
cervical epithelial cell deterioration.
Eur J Histochem. 2025;69. PubMed Abstract available
WAN K, Yu L, Feng S, Xie Z, et al A novel bispecific affitoxin simultaneously targeting E7 of HPV16/18 types:
superior anti-tumor activity and EMT reversal in HPV-driven cervical cancer
therapy.
J Transl Med. 2025;23:992. PubMed Abstract available
GUI Z, Ye Y, Li Y, Ren Z, et al Corrigendum to "Construction of a novel cancer?associated fibroblast?related
signature to predict clinical outcome and immune response in cervical cancer"
[Transl Oncol.?2024;46:102001].
Transl Oncol. 2025;61:102499. PubMed
NEMICHAND, Shukla S, Singh P, Pradhan A, et al Enhanced epithelial fluorescence sensitivity using an oblique-angled fiber optic
probe for epithelial cancer diagnosis: a modified Monte Carlo simulation study.
Appl Opt. 2025;64:7271-7280. PubMed Abstract available
MORADI M, Jiang R, Liu Y, Madondo M, et al Automated Treatment Planning for Interstitial HDR Brachytherapy for Locally
Advanced Cervical Cancer using Deep Reinforcement Learning.
ArXiv [Preprint]. 2025 Jun 13:arXiv:2506.11957. PubMed Abstract available
LI R, Song R, Jiao Y, Liu D, et al Albumin-bound paclitaxel combined with lobaplatin using different administration
methods in the treatment of cervical cancer: Study on the efficacy and its effect
on immune function and inflammatory response.
Pak J Med Sci. 2025;41:2260-2265. PubMed Abstract available
STANIEWSKA E, Stankiewicz M, Burchardt E, Grudzien K, et al The prognostic value of baseline 18FDG - Positron Emission Tomography - Computed
Tomography in cervical cancer patients treated with definitive chemoradiotherapy
- External multicentre validation model.
Phys Imaging Radiat Oncol. 2025;35:100829. PubMed Abstract available
SEBASTIAN A, Salih N, Jose S, Al Dughaishi T, et al Cervical Deciduosis in Early Pregnancy Mimicking Malignancy: A report of two
cases.
Sultan Qaboos Univ Med J. 2025;25:547-551. PubMed Abstract available
VOKURKA S, Mastny L, Vojtisek R, Lypka K, et al Identifying Leukopenia, Renal Dysfunction and Other Factors Limiting Concomitant
Chemoradiotherapy in Locally Advanced Cervical Cancer: A Way to Focus on the
Importance of Supportive Care and Potentially Improve Treatment Results?
Cureus. 2025;17:e90633. PubMed Abstract available
SIDDIQUE AB, Sultana C, Roy C, Rahman T, et al Assessment of Knowledge, Attitudes, and Practices Concerning Cervical Cancer
Among Women of Early Reproductive Age in Bangladesh: A Cross-Sectional Study.
Health Sci Rep. 2025;8:e71276. PubMed Abstract available
ZHAO L, Zhai Y, Meng L, Ren Y, et al Pegylated recombinant human granulocyte colony-stimulating factor enhances
radiotherapy completion and safety in concurrent chemoradiotherapy for cervical
cancer: a retrospective analysis.
Front Oncol. 2025;15:1640418. PubMed Abstract available
SUN Z, Qi D, Liu L, Ai W, et al Role of the ALK gene and PI3K/Akt/NF-kappaB signaling pathway in cervical cancer
precancerous lesions.
Front Oncol. 2025;15:1619703. PubMed Abstract available
YANG X, Gu Y Precision delivery of estrogen receptor antagonists using bioorthogonal
chemistry-based intelligent nanocarriers to overcome cervical cancer drug
resistance.
Mater Today Bio. 2025;34:102218. PubMed Abstract available
ZAMMIT C, Ashfaq M, Boyd L, Paton C, et al Considerations in the development of an mHealth approach to increase cervical
screening participation in primary care in Victoria, Australia.
Aust J Prim Health. 2025;31:PY25101. PubMed Abstract available
RANGARAJ K, Vasudevan MT, Rangaraj S, Kumar R, et al Synergistic Antiproliferative Effects of EGCG and Myricetin on Cervical Cancer
Biomarkers in ME180 and SiHa Cell Lines.
Curr Gene Ther. 2025 Sep 18. doi: 10.2174/0115665232363374250901071820. PubMed Abstract available
LIU J, Zhu M, Li L, Zang L, et al Machine Learning based Radiomics from Multi-parametric Magnetic Resonance Imaging
for Predicting Lymph Node Metastasis in Cervical Cancer.
Curr Med Imaging. 2025 Sep 18. doi: 10.2174/0115734056376718250904221020. PubMed Abstract available
ZHOU Y, Chen G, Zhu Y Ketamine Induces Mitochondrial Fission and Dysfunction in Cervical Cancer Cells
via RhoA-Dependent DRP-1 Activation.
J Biochem Mol Toxicol. 2025;39:e70500. PubMed Abstract available
DANG T, You Y, Wei L, Li Q, et al ICAT drives lactylation of tumor-associated macrophages via the c-Myc-ENO1 axis
to promote cervical cancer progression.
Free Radic Biol Med. 2025 Sep 19:S0891-5849(25)00988. PubMed Abstract available
ABBAS HH, Rodrigues FAE, Krishnan D, Ramasamy S, et al High-throughput nucleotide sequencing reveals new circulatory miRNA genes in
cervical cancer patients.
Comput Biol Med. 2025;197. PubMed Abstract available
LIU Y, Li H, Zheng Z, Niu A, et al Corrigendum to "Rosa rugosa polysaccharide induces autophagy-mediated apoptosis
in human cervical cancer cells via the PI3K/AKT/mTOR pathway" [Int. J. Biol.
Macromol. 212 (2022) P257 P274].
Int J Biol Macromol. 2025 Sep 19:147574. doi: 10.1016/j.ijbiomac.2025.147574. PubMed
PANT A, Thangavel G, Mathew S, Nath A, et al A comparison of the cost-effectiveness of HPV (self-sampling and health care
provider sampling) versus VIA for cervical cancer screening in India.
J Cancer Policy. 2025;46:100642. PubMed Abstract available
CERQUEIRA-SILVA T, Barral-Netto M, Boaventura VS Effect of Brazil's national human papillomavirus vaccination programme on the
incidence of cervical cancer and cervical intraepithelial neoplasia grade 3 in
women aged 20-24 years: a population-based study.
Lancet Glob Health. 2025;13:e1715-e1722. PubMed Abstract available
YAN T, Zhang MM, Deng XY, Imam M, et al Design and synthesis of novel quinoline-chalcone derivatives as dual inhibitors
of tubulin polymerization and P-glycoprotein to overcome cisplatin resistance in
cervical cancer.
Bioorg Chem. 2025;165:109006. PubMed Abstract available
DORALI P, Damgacioglu H, Amboree TL, Ortiz AP, et al Magnitude of persistent poverty and cervical cancer incidence, stage at
diagnosis, and mortality.
JNCI Cancer Spectr. 2025 Sep 20:pkaf091. doi: 10.1093. PubMed Abstract available
MIYATA Y, Ogo E, Murotani K, Nagahiro K, et al A new hyaluronate gel spacer and injection technique for cervical cancer
brachytherapy: a technical report.
J Radiat Res. 2025 Sep 17:rraf055. doi: 10.1093. PubMed Abstract available
LIU S, Fang C, Wu X, Zhu J, et al Chemoradiotherapy With or Without Simultaneous Integrated Boost for Cervical
Cancer With Full-Thickness Stromal Invasion: A Phase 3 Randomized Clinical Trial.
JAMA Netw Open. 2025;8:e2532501. PubMed Abstract available
BAI X, Wang H, Guo Q Mechanisms of T cell-mediated immune evasion in cervical cancer: a comprehensive
bibliometric analysis and future research directions.
Immunol Med. 2025 Sep 19:1-21. doi: 10.1080/25785826.2025.2560214. PubMed Abstract available
KLEIJBERG M, Eriksson LE Transgender Men's and Non-Binary People's Experiences of Cervical Cancer
Screening-A Journey Mapping Approach.
J Clin Nurs. 2025 Sep 19. doi: 10.1111/jocn.70113. PubMed Abstract available
TONG Y, Xu L, Sun Y, Zhang K, et al Identification of Bacterial Lipopolysaccharide-Related Molecular Subtypes and
Development of a Four-Gene Prognostic Risk Model in Cervical Cancer.
Int J Womens Health. 2025;17:2979-2998. PubMed Abstract available
DYKENS JA, Sougou NM, Gassama O, Dieng NM, et al Rationale and Protocol Design for the Adaptation and Implementation of a Patient
Navigation Program for Cervical Cancer Screening Across Contexts in Senegal.
Int J Womens Health. 2025;17:3013-3029. PubMed Abstract available
TAKEKUMA M, Nishio S, Yamaguchi S, Yunokawa M, et al Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results
of Japanese population from BEATcc.
J Gynecol Oncol. 2025 May 19. doi: 10.3802/jgo.2025. PubMed Abstract available
CHEN Y, Chen Q, Guo X, Zheng Q, et al Suppressor of TCR signaling 2 (Sts-2) as a potential immunotherapy target and
prognostic biomarker in cervical cancer.
J Gynecol Oncol. 2025 Sep 10. doi: 10.3802/jgo.2026. PubMed Abstract available
MATSUDA R, Nishio H, Ueno A, Matsui T, et al Diagnostic accuracy of intraoperative frozen section at radical abdominal
trachelectomy for early-stage cervical cancer.
J Gynecol Oncol. 2025 Sep 12. doi: 10.3802/jgo.2026. PubMed Abstract available
TAO H, Wang L, Ding Y, Yi L, et al Microbial and Metabolic Disorders in Cervical Cancer: Structural Insights,
Biomarkers, Mechanisms, and Therapeutic Strategies.
Cancer Sci. 2025 Sep 18. doi: 10.1111/cas.70201. PubMed Abstract available
WANG H, Zhou J, Zhang J, Yao W, et al LOXL1-AS1 suppresses ferroptosis in cervical cancer through m6A-dependent
regulation of TFRC.
J Mol Histol. 2025;56:320. PubMed Abstract available
WANG Z, Wang SM, Wang HK, Yin J, et al [Epidemiology, prevention and control of cervical cancer in middle-aged and
elderly women in China].
Zhonghua Zhong Liu Za Zhi. 2025;47:840-849. PubMed Abstract available
WANG H, Liu G, Chen Y, Zhang B, et al The combination of a small molecular prodrug and hyaluronic acid-tocopherol
assembly as a nano-agent for the synergistic therapy of cervical cancer.
Int J Biol Macromol. 2025 Sep 16:147707. doi: 10.1016/j.ijbiomac.2025.147707. PubMed Abstract available
PARVIZI M, Taghizadeh-Teymorloei M, Vaezi M, Bakhshandeh M, et al Effects of chemoradiotherapy on plasma oncogenic miRNAs as biomarkers in cervical
cancer patients: A prospective observational study.
Sci Prog. 2025;108:368504251380636. PubMed Abstract available
LIU Y, Ding S, Liu H A genome-wide analysis of YY1 and TFAP2 competition on overlapping motifs reveals
their roles in HPV-induced carcinogenesis.
PLoS Pathog. 2025;21:e1013524. PubMed Abstract available
YANG W, Jiang G, Liu Y, Zhang L, et al Combination of photodynamic therapy and estrogen cream for menopause women with
cervical low-grade squamous intraepithelial lesion with human papillomavirus
infection.
Photodiagnosis Photodyn Ther. 2025;55:104791. PubMed Abstract available
HU X, Guo X, Sha J, Dou Y, et al Analysis of the efficacy of photodynamic therapy in treating cervical lesions and
HPV infections and its influencing factors.
Photodiagnosis Photodyn Ther. 2025;55:104786. PubMed Abstract available
ZHANG J, Wen KY, Liang J, Diamond V, et al Feasibility and Acceptability of Human Papillomavirus Based Self-sampling in
Underserved Minorities in the United States: A Scoping Review.
J Low Genit Tract Dis. 2025;29:348-358. PubMed Abstract available
TERZIOGLU HG, Aragao A, Barroeta JE Expertise in Gynecological Pathology Impacts Diagnosis of Atypical Glandular Cell
Category in Cervical Cytology.
J Low Genit Tract Dis. 2025;29:297-303. PubMed Abstract available
BERTELSEN VM, Booth BB, Tranberg M, Kristensen CB, et al Dynamic Spectral Imaging and Regular Colposcopy in CIN2+ Detection for
HPV-Positive and/or Low-Grade Cytology Referrals.
J Low Genit Tract Dis. 2025;29:335-341. PubMed Abstract available
CAI H, Liu Y, Che Y, Lou Y, et al Efficacy of photodynamic therapy for cervical intraepithelial neoplasia grade 3:
a retrospective study.
Photodiagnosis Photodyn Ther. 2025;55:104773. PubMed Abstract available
PENG K, Chen X, Zhang Y, Liu L, et al Lactobacillus crispatus-derived nCEV vesicles promote cutaneous wound healing and
inhibit HPV16 infection.
mSystems. 2025;10:e0068325. PubMed Abstract available
KYEI GK, Kyei EF, Ansong R Determinants of HPV Vaccine Uptake in Women in the United States: A Scoping
Review of Socioecological Influences.
Policy Polit Nurs Pract. 2025;26:256-272. PubMed Abstract available
BILLINGSLEY CL, Doud EH, Smith-Kinnaman W, Mosley AL, et al Proliferative proteome induced by HPV 16E6 and NFX1-123 partnership in
longitudinal keratinocyte cultures.
J Virol. 2025 Aug 13:e0096725. doi: 10.1128/jvi.00967. PubMed Abstract available
HIGUCHI D, Yamaguchi M, Fujii E, Kato MK, et al TP53 gene and pathway alterations in gastric-type adenocarcinoma of the cervix.
JNCI Cancer Spectr. 2025;9:pkaf082. PubMed Abstract available
WATANABE K, Tabuchi T, Zaitsu M Occupational disparities in common cancer screening participation among workers:
a nationwide cross-sectional study in Japan.
J Occup Health. 2025;67:uiaf046. PubMed Abstract available
WANG L, Wei Y, Wu A, Hong Z, et al Efficacy of different 5-aminolevulinic acid photodynamic therapy regimens in
managing HSIL/CIN2 among reproductive-age women: A retrospective study.
Photodiagnosis Photodyn Ther. 2025;55:104749. PubMed Abstract available
LEE T, Richardson-Powell V, Chen J, Garvey D, et al Usability of Speculum-Compatible Injection Devices for Administering Ethyl
Cellulose-Ethanol Ablation to Treat Cervical Neoplasia in Low- and Middle-Income
Countries.
Ann Biomed Eng. 2025;53:2658-2668. PubMed Abstract available
TOLEDO RG, Dias Y, Martin RRH, Hacker MR, et al General Versus Local Anesthesia in Loop Electrosurgical Excision Procedures: A
Systematic Review and Meta-Analysis.
J Low Genit Tract Dis. 2025;29:359-364. PubMed Abstract available
HARINATH L, Matsko J, Colaizzi A, Zeng X, et al Assessment of reprocessed ThinPrep cytology cases after glacial acetic acid wash
procedure using the Hologic Genius Digital Diagnostics System.
J Am Soc Cytopathol. 2025;14:347-357. PubMed Abstract available
MACAJOVA M, Huntosova V, Kundekova B, Meta M, et al Establishment of C-33A cervical carcinoma spheroids on Japanese quail CAM:
relevance in assessment of photodiagnosis and photodynamic therapy mediated by
hypericin.
Photodiagnosis Photodyn Ther. 2025;55:104699. PubMed Abstract available
SANTOS SAD, Sato MY, Basilio PHG, Pereira ME, et al Comparison between the safety of the HPV vaccine versus placebo: a systematic
review and meta-analysis of randomized clinical trials.
J Pediatr (Rio J). 2025;101:101411. PubMed Abstract available
LI J, Fang M Nutritional Modulation Improves the Immune Function of Cervical Carcinoma
Patients Receiving Radiotherapy: a Retrospective Analysis of 106 Cases.
Tohoku J Exp Med. 2025;267:41-47. PubMed Abstract available
HABESHIAN TS, Xu L, Hahn EE, Ngo-Metzger Q, et al Evaluating the trend of time to colposcopy follow-up among women with a positive
primary human papillomavirus screening result at Kaiser Permanente Southern
California.
Am J Obstet Gynecol. 2025;233:305. PubMed Abstract available
MUNTINGA CLP, Schellekens HCJ, Penders CGJ, van Meir H, et al Improving imiquimod use in cervical high-grade squamous intraepithelial lesions:
A qualitative study.
Acta Obstet Gynecol Scand. 2025;104:1712-1719. PubMed Abstract available
HEINONEN A, Kalliala I, Hammer A, Cruickshank M, et al Survey of practices in the European Federation for Colposcopy: HPV vaccination
after treatment for cervical precancerous lesions.
Acta Obstet Gynecol Scand. 2025;104:1980-1985. PubMed Abstract available
TALIA KL, Hawkes D, Zhang G, Jamison J, et al HPV42: A Common Low-Risk HPV Type Associated With Distinctive Cervicovaginal and
Cutaneous Neoplasia.
Am J Surg Pathol. 2025;49:992-1003. PubMed Abstract available
MATHEWS CS, Sargent A, Cuschieri K, Rebolj M, et al HPValidate-human papillomavirus testing with DNA and mRNA assays on
self-collected samples in cervical screening: comparison of test characteristics
on three self-sampling devices.
Br J Cancer. 2025;133:665-673. PubMed Abstract available
GORI S, Venturelli F, Carozzi F, Giorgi Rossi P, et al Italian guidelines for cervical cancer screening. Multisocietal recommendations
on the use of biomarkers in HPV screening with risk-based approach and GRADE
methodology.
Br J Cancer. 2025 Sep 11. doi: 10.1038/s41416-025-03161. PubMed Abstract available
HARDIE AN, Wenzel HHB, Schnack TH, Van der Aa MA, et al Response to Letter Re: Oncological outcomes after radical hysterectomy followed
by adjuvant (chemo)radiation or no further treatment in women with cervical
cancer FIGO 2018 IB2-IIA2- a multinational population-based cohort study.
Eur J Cancer. 2025;228:115743. PubMed
RAMOS-CASALLAS A, Cardona-Mendoza A, Perdomo-Lara SJ, Rico-Mendoza A, et al Performance evaluation of machine learning models in cervical cancer diagnosis:
Systematic review and meta-analysis.
Eur J Cancer. 2025;229:115768. PubMed Abstract available
KEERTHANA A, Anantharaju A, Ansar PTM, Kala, et al Real-time detection of premalignant cervical lesion using Artificial Intelligence
(AI) model in multispectral imaging system.
Eur J Obstet Gynecol Reprod Biol. 2025;313:114579. PubMed Abstract available
KIM S, Kwon G, Kim H, Yun H, et al Full-term delivery after antepartum vaginal myomectomy for prolapsed myoma
causing uterus distortion: A case report and literature review.
Eur J Obstet Gynecol Reprod Biol. 2025;313:114580. PubMed Abstract available
ZHOU N, Beavis AL, Lin LL, Neibart SS, et al Embracing and implementing the WHO cervical cancer elimination campaign goals: A
consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care
standards for cervical cancer patients in the U.S.
Gynecol Oncol. 2025;200:193-202. PubMed Abstract available
NEIBART S, Zhou N, Chino J, Earles T, et al Health equity, disparities, and barriers to cervical cancer care in the U.S.: A
consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS addressing the WHO
cervical Cancer elimination campaign goals related to treatment.
Gynecol Oncol. 2025;200:186-192. PubMed Abstract available
NEIBART SS, Lin LL, Einstein MH, Teoh D, et al Minimum standards for radiation therapy in the treatment of cervical cancer in
the U.S.: A consensus statement by SGO, ASTRO, and ABS addressing the WHO
Cervical Cancer Elimination Campaign goals.
Gynecol Oncol. 2025;200:180-185. PubMed Abstract available
MATSUBARA M, Otani T, Kawakami F, Koike A, et al Cervical adenocarcinoma risk stratification using histotype and invasion pattern:
a multicenter retrospective study by the KAMOGAWA Study Group.
Gynecol Oncol. 2025;200:112-121. PubMed Abstract available
RAGLAND K, Pogue J, Simiele E, Simiele S, et al The use of transrectal ultrasound to improve gynecologic interstitial applicator
implantation.
Gynecol Oncol. 2025;200:88-95. PubMed Abstract available
SCHAAFSMA M, Schuurman TN, Bekkers RLM, Dunne FR, et al The risk for residual AIS/CIN3+ after the first conservative surgical procedure
for cervical adenocarcinoma in situ - A Dutch retrospective cohort study.
Gynecol Oncol. 2025;200:44-50. PubMed Abstract available
AN J, Li G, Zhang Y, Feng M, et al Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical
cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907).
Gynecol Oncol. 2025;202:33-40. PubMed Abstract available
LIU H, Zou Z, Zhang L Reply to 'Comments on "HPV vaccination is highly effective and cost-effective for
cervical cancer prevention in women living with HIV in China: A
cost-effectiveness analysis"'.
Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70129. PubMed
LIU Z, Tong X Comments on "HPV vaccination is highly effective and cost-effective for cervical
cancer prevention in women living with HIV in China: A cost-effectiveness
analysis".
Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70130. PubMed
CASTANEDA KM, Vermeulen KM, van der Aa M, Schuuring E, et al Trends in cervical cancer incidence in the Netherlands: A join-point and
age-period-cohort analysis (1989-2023).
Int J Cancer. 2025 Sep 8. doi: 10.1002/ijc.70134. PubMed Abstract available
YANAIHARA N, Tse KY, Lee SJ, Yoo JG, et al Immune checkpoint inhibitors in gynecologic oncology: Current status and
perspectives.
Int J Gynaecol Obstet. 2025;171 Suppl 1:166-188. PubMed Abstract available
WILAILAK S, Kengsakul M, Kehoe S Strategic approaches for global cervical cancer elimination: An update review and
call for national action.
Int J Gynaecol Obstet. 2025;171 Suppl 1:120-128. PubMed Abstract available
BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al Cancer of the cervix uteri: 2025 update.
Int J Gynaecol Obstet. 2025;171 Suppl 1:87-108. PubMed Abstract available
RUZINDANA K, Anorlu RI Global disparities in gynecologic cancer outcomes: A call for action.
Int J Gynaecol Obstet. 2025;171 Suppl 1:210-220. PubMed Abstract available
MCCLUGGAGE WG New histopathological and molecular findings in gynecological cancers.
Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70283. PubMed Abstract available
PAIBOONBORIRAK C, Abu-Rustum NR, Wilailak S Artificial intelligence in the diagnosis and management of gynecologic cancer.
Int J Gynaecol Obstet. 2025 Apr 25. doi: 10.1002/ijgo.70094. PubMed Abstract available
DURMUS Y, Kirdag MK, Yilmaz K, Aydin E, et al Plexiform neurofibroma infiltrating uterine cervix and parametrium, causing
hydronephrosis: A case report and review of the literature.
Int J Gynaecol Obstet. 2025 May 16. doi: 10.1002/ijgo.70212. PubMed Abstract available
YANG XL, Zeng Z, Yan JF, Zhang FQ, et al Does the addition of radiation to adjuvant chemotherapy improve the survival for
early-stage (tumor size
Int J Gynaecol Obstet. 2025;171:362-370. PubMed Abstract available
BLADE AT, Del Mar Ramirez Mena M, de la Fuente Valero J, Sanchez RO, et al HPV vaccination coverage rate in women undergoing conization for cervical
intraepithelial neoplasia in Spain: The COVAR study.
Int J Gynaecol Obstet. 2025 May 2. doi: 10.1002/ijgo.70170. PubMed Abstract available
MARTINS JC, Gouveia MC, Bonadio RC, Scaranti M, et al When the blood speaks first: circulating tumor DNA as a biomarker in locally
advanced cervical cancer.
Int J Gynecol Cancer. 2025;35:102020. PubMed
KOBAYASHI M, Nakagawa S, Masuda T, Kakuda M, et al Clinical and pathological characteristics and outcomes of small cell
neuroendocrine carcinoma of the uterine cervix.
Int J Gynecol Cancer. 2025;35:102011. PubMed Abstract available
BAEK JY, Park W, Cho WK, Kim HS, et al Surgery plus post-operative radiotherapy versus definitive chemoradiotherapy in
locally advanced endocervical adenocarcinoma.
Int J Gynecol Cancer. 2025;35:102013. PubMed Abstract available
GAO X, Kong Y, Ning Y, Cui Z, et al Clinical characteristics and prognosis of rhabdomyosarcoma in the female
reproductive system: a population-based analysis using SEER data.
Int J Gynecol Cancer. 2025;35:101989. PubMed Abstract available
ISMAIL M, Refky B, Mostafa N, Elazab M, et al From silence to action: Egypt's path to national cervical cancer prevention.
Int J Gynecol Cancer. 2025 Aug 26:102121. doi: 10.1016/j.ijgc.2025.102121. PubMed
WANG Y, Zhang X, Wang F, Chen W, et al Dosimetric and Clinical Effects of Polyethylene Glycol Gel in Radical Concurrent
Chemoradiotherapy for Cervical Cancer: A Phase III Prospective Multicenter
Randomized Controlled Trial.
Int J Radiat Oncol Biol Phys. 2025 Aug 26:S0360-3016(25)06196. PubMed Abstract available
PAI V, Wairkar T, Menon S, Chaudhari S, et al PD-L1 expression in locally advanced cervical cancer: A pilot cross clone
comparison study.
Int J Radiat Oncol Biol Phys. 2025 Sep 4:S0360-3016(25)06207. PubMed Abstract available
SAPIENZA LG, Guitmann G, Morris CG, Okunieff PG, et al A systematic study on local failure events post chemoradiotherapy for cervical
cancer: understanding the impact of baseline lateral anatomical compartment
involvement.
Int J Radiat Oncol Biol Phys. 2025 Sep 17:S0360-3016(25)06281. PubMed Abstract available
OSTRBENK A, Pedersen H, Poljak M, Bonde J, et al The Allplex HPV HR Detection assay fulfils international guideline requirements
for primary cervical screening on SurePath samples and qualifies as a
second-generation HPV comparator test.
J Clin Virol. 2025;180:105853. PubMed Abstract available
TERGAS AI, Einstein MH The Future of Cervical Cancer Screening Is Now.
Obstet Gynecol. 2025;146:3-5. PubMed
CHANG Y, Li T, Zhou Q, Kang D, et al Effectiveness of Artificial Intelligence-Assisted Colposcopy in a
Resource-Limited Population.
Obstet Gynecol. 2025;146:545-554. PubMed Abstract available
BOMANS L, Ramirez AT, Hillemanns P, Gultekin M, et al Prediction of Treatment Failure After Excisional Treatment of Cervical Precancer:
A Systematic Review and Meta-analysis.
Obstet Gynecol. 2025;146:487-499. PubMed Abstract available
SERBAN M, Spampinato S, de Leeuw A, Fortin I, et al Evaluation of brachytherapy applicators and their association with morbidity and
local control in cervix cancer: An EMBRACE I analysis.
Radiother Oncol. 2025;210:110954. PubMed Abstract available
LIM MSH, Tan SSN, Wan Maharuddin IB, Voon PJ, et al Survival rates of cervical cancer patients in Sarawak: a single-centre referral
study.
BMC Cancer. 2025;25:1381. PubMed
YANG Q, Han X Prognostic value of risk factors in cervical squamous cell carcinoma based on
tumour infiltration depth.
BMC Cancer. 2025;25:1412. PubMed Abstract available
KASSA B, Mohammed A, Wassie GT Parents' acceptance of human papilloma virus vaccination for their daughters in
adet town, North Gojjam zone, Northwest Ethiopia: A mixed method study.
PLoS One. 2025;20:e0330911. PubMed Abstract available
DEN'O ZD, Paulos W, Markos D, Oche WO, et al Human papilloma virus vaccination uptake and associated factors among adolescent
girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
PLoS One. 2025;20:e0330760. PubMed Abstract available
BULAMBA RM, Kyasanku E, Nalugoda F, Daama A, et al Assessing Knowledge, Uptake and Factors associated with cervical cancer screening
among women in selected communities of Wakiso district in Uganda: A
population-based study.
PLoS One. 2025;20:e0317641. PubMed Abstract available
OLUBODUN T, Olaniran A, Awowole IO, Ohazurike E, et al Practice of opportunistic cervical cancer screening and health education among
health workers in Ogun State, Nigeria: A qualitative study of barriers and
facilitators.
PLoS One. 2025;20:e0316883. PubMed Abstract available
MWANGI JH, Mbeje PN, Mtshali GN Exploring the roles of male partners in the transmission, prevention and control
of cervical cancer in Central Kenya: A qualitative study.
PLoS One. 2025;20:e0324575. PubMed Abstract available
JAFRIN S, Aziz MA, Barek MA, Reza MS, et al Association of missense variant DCLRE1B rs3761936 with breast and cervical cancer
risk-A case-control study.
PLoS One. 2025;20:e0331492. PubMed Abstract available
WYNN A, Harris D, Modest A, Reyes MF, et al Short-term costs and cost-efficiency of HPV triage strategies in a high
HIV-prevalence setting: Evidence from Botswana.
PLoS One. 2025;20:e0328803. PubMed Abstract available
KHIRUDDIN K, Mustafa WA, Islam MA, Jamaludin KR, et al Comparative analysis of cervical cancer classification of DPAGCHE-enhanced Pap
smear images using convolutional neural network models.
PLoS One. 2025;20:e0330103. PubMed Abstract available
CHEN D, Wu H, Huang F, Tan K, et al Prognostic follow-up of high-grade squamous intraepithelial lesions of the cervix
near the conization margin: A retrospective cohort study.
PLoS One. 2025;20:e0331184. PubMed Abstract available
BASHORUN AO, Kotei L, Jallow AF, Jawla O, et al Human papillomavirus, sexually transmitted infections, and antimicrobial
resistance in West Africa: Estimating population burden and understanding
exposures to accelerate vaccine impact and drive new interventions: The PHASE
survey protocol.
PLoS One. 2025;20:e0332842. PubMed Abstract available
NUOVO GJ, Tili E, Croce CM Loss of ICOSL expression in the progression to cervical carcinoma.
Proc Natl Acad Sci U S A. 2025;122:e2509425122. PubMed Abstract available
